These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 34344463)

  • 1. Association between HLA genotypes and COVID-19 susceptibility, severity and progression: a comprehensive review of the literature.
    Migliorini F; Torsiello E; Spiezia F; Oliva F; Tingart M; Maffulli N
    Eur J Med Res; 2021 Aug; 26(1):84. PubMed ID: 34344463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of HLA genotypes, AB0 blood type and chemokine receptor 5 mutant CD195 with the clinical course of COVID-19.
    Fischer JC; Schmidt AG; Bölke E; Uhrberg M; Keitel V; Feldt T; Jensen B; Häussinger D; Adams O; Schneider EM; Balz V; Enczmann J; Rox J; Hermsen D; Schulze-Bosse K; Kindgen-Milles D; Knoefel WT; van Griensven M; Haussmann J; Tamaskovics B; Plettenberg C; Scheckenbach K; Corradini S; Pedoto A; Maas K; Schmidt L; Grebe O; Esposito I; Ehrhardt A; Peiper M; Buhren BA; Calles C; Stöhr A; Lichtenberg A; Freise NF; Lutterbeck M; Rezazadeh A; Budach W; Matuschek C
    Eur J Med Res; 2021 Sep; 26(1):107. PubMed ID: 34530915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA repertoire of 115 UAE nationals infected with SARS-CoV-2.
    Alnaqbi H; Tay GK; Jelinek HF; Francis A; Alefishat E; El Haj Chehadeh S; Tahir Saeed A; Hussein M; Laila Salameh ; Mahboub BH; Uddin M; Alkaabi N; Alsafar HS;
    Hum Immunol; 2022 Jan; 83(1):1-9. PubMed ID: 34462158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MHC Haplotyping of SARS-CoV-2 Patients: HLA Subtypes Are Not Associated with the Presence and Severity of COVID-19 in the Israeli Population.
    Ben Shachar S; Barda N; Manor S; Israeli S; Dagan N; Carmi S; Balicer R; Zisser B; Louzoun Y
    J Clin Immunol; 2021 Aug; 41(6):1154-1161. PubMed ID: 34050837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA and AB0 Polymorphisms May Influence SARS-CoV-2 Infection and COVID-19 Severity.
    Amoroso A; Magistroni P; Vespasiano F; Bella A; Bellino S; Puoti F; Alizzi S; Vaisitti T; Boros S; Grossi PA; Trapani S; Lombardini L; Pezzotti P; Deaglio S; Brusaferro S; Cardillo M;
    Transplantation; 2021 Jan; 105(1):193-200. PubMed ID: 33141807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human Leukocyte Antigen Complex and Other Immunogenetic and Clinical Factors Influence Susceptibility or Protection to SARS-CoV-2 Infection and Severity of the Disease Course. The Sardinian Experience.
    Littera R; Campagna M; Deidda S; Angioni G; Cipri S; Melis M; Firinu D; Santus S; Lai A; Porcella R; Lai S; Rassu S; Scioscia R; Meloni F; Schirru D; Cordeddu W; Kowalik MA; Serra M; Ragatzu P; Carta MG; Del Giacco S; Restivo A; Deidda S; Orrù S; Palimodde A; Perra R; Orrù G; Conti M; Balestrieri C; Serra G; Onali S; Marongiu F; Perra A; Chessa L
    Front Immunol; 2020; 11():605688. PubMed ID: 33343579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between human leukocyte antigen alleles and COVID-19 disease severity.
    Hajeer A; Jawdat D; Massadeh S; Aljawini N; Abedalthagafi MS; Arabi YM; Alaamery M
    J Infect Public Health; 2024 Sep; 17(9):102498. PubMed ID: 39173558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigen presentation in SARS-CoV-2 infection: the role of class I HLA and ERAP polymorphisms.
    Saulle I; Vicentini C; Clerici M; Biasin M
    Hum Immunol; 2021 Aug; 82(8):551-560. PubMed ID: 34116863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human Leukocyte Antigen Susceptibility Map for Severe Acute Respiratory Syndrome Coronavirus 2.
    Nguyen A; David JK; Maden SK; Wood MA; Weeder BR; Nellore A; Thompson RF
    J Virol; 2020 Jun; 94(13):. PubMed ID: 32303592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible role of HLA class-I genotype in SARS-CoV-2 infection and progression: A pilot study in a cohort of Covid-19 Spanish patients.
    Iturrieta-Zuazo I; Rita CG; García-Soidán A; de Malet Pintos-Fonseca A; Alonso-Alarcón N; Pariente-Rodríguez R; Tejeda-Velarde A; Serrano-Villar S; Castañer-Alabau JL; Nieto-Gañán I
    Clin Immunol; 2020 Oct; 219():108572. PubMed ID: 32810602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-E*01:01 + HLA-E*01:01 genotype confers less susceptibility to COVID-19, while HLA-E*01:03 + HLA-E*01:03 genotype is associated with more severe disease.
    Hosseini E; Minagar A; Ghasemzadeh M; Arabkhazaeli A; Ghasemzadeh A
    Hum Immunol; 2023 Apr; 84(4):263-271. PubMed ID: 36822912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Human Leukocyte Antigen Alleles with COVID-19 Severity and Mortality in a Spanish Population.
    Lobato-Martinez E; Muriel-Serrano J; García-Payá E; Gonzalez-de-la-Aleja P; Garcia-Sevila R; Navarro-de-Miguel M; Marco-de-la-Calle F; Ramos-Rincon JM; Sanchez-Martinez R
    Medicina (Kaunas); 2024 Aug; 60(9):. PubMed ID: 39336433
    [No Abstract]   [Full Text] [Related]  

  • 13. Frequency of HLA alleles among COVID-19 infected patients: Preliminary data from Saudi Arabia.
    Naemi FMA; Al-Adwani S; Al-Khatabi H; Al-Nazawi A
    Virology; 2021 Aug; 560():1-7. PubMed ID: 34015620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection.
    Marchal A; Cirulli ET; Neveux I; Bellos E; Thwaites RS; Schiabor Barrett KM; Zhang Y; Nemes-Bokun I; Kalinova M; Catchpole A; Tangye SG; Spaan AN; Lack JB; Ghosn J; Burdet C; Gorochov G; Tubach F; Hausfater P; ; ; ; ; ; ; ; ; ; Dalgard CL; Zhang SY; Zhang Q; Chiu C; Fellay J; Grzymski JJ; Sancho-Shimizu V; Abel L; Casanova JL; Cobat A; Bolze A
    HGG Adv; 2024 Jul; 5(3):100300. PubMed ID: 38678364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA alleles associated with susceptibility and severity of the COVID-19 in Vietnamese.
    Hai NTT; Nhung VP; Tam NTT; Ngoc TTB; Thuong MTH; Dai HV; Duong NT; Hai NV; Ton ND; Thach PN; Ha NH
    Hum Immunol; 2024 May; 85(3):110796. PubMed ID: 38580537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA-B*15 predicts survival in Egyptian patients with COVID-19.
    Abdelhafiz AS; Ali A; Fouda MA; Sayed DM; Kamel MM; Kamal LM; Khalil MA; Bakry RM
    Hum Immunol; 2022 Jan; 83(1):10-16. PubMed ID: 34607724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of HLA gene polymorphism with susceptibility, severity, and mortality of COVID-19: A systematic review.
    Deb P; Zannat KE; Talukder S; Bhuiyan AH; Jilani MSA; Saif-Ur-Rahman KM
    HLA; 2022 Apr; 99(4):281-312. PubMed ID: 35067002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activating Killer-Cell Immunoglobulin-Like Receptors Are Associated With the Severity of Coronavirus Disease 2019.
    Bernal E; Gimeno L; Alcaraz MJ; Quadeer AA; Moreno M; Martínez-Sánchez MV; Campillo JA; Gomez JM; Pelaez A; García E; Herranz M; Hernández-Olivo M; Martínez-Alfaro E; Alcaraz A; Muñoz Á; Cano A; McKay MR; Muro M; Minguela A
    J Infect Dis; 2021 Jul; 224(2):229-240. PubMed ID: 33928374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Killer-cell immunoglobulin-like receptor polymorphism is associated with COVID-19 outcome: Results of a pilot observational study.
    Niño-Ramírez JE; Alcoceba M; Gutiérrez-Zufiaurre MN; Marcos M; Gil-Etayo FJ; Bartol-Sánchez MR; Eiros R; Chillón MC; García-Álvarez M; Terradillos-Sánchez P; Presa D; Muñoz JL; López-Bernús A; López-Sánchez E; González-Calle D; Sánchez PL; Compán-Fernández O; González M; García-Sanz R; Boix F
    HLA; 2024 Aug; 104(2):e15640. PubMed ID: 39148254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does immune recognition of SARS-CoV2 epitopes vary between different ethnic groups?
    Bose T; Pant N; Pinna NK; Bhar S; Dutta A; Mande SS
    Virus Res; 2021 Nov; 305():198579. PubMed ID: 34560183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.